Boe Sandahl Sørensen (Boe S Sorensen, Boe Sorensen, Boe S Sørensen, Boe Sandahl Sorensen)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 20

Top Topics

Advanced Non Small Cell Lung Cancer

Epidermal Growth Factor Receptor

Circulating Tumor

Top Venues

European journal of immunology

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Christoffer Trier Månsson, Louise Skov Thomsen, Peter Meldgaard, Anders Lade Nielsen, Boe Sandahl Sørensen
Integration of Cell-Free DNA End Motifs and Fragment Lengths Can Identify Active Genes in Liquid Biopsies. International journal of molecular sciences 25 (2) (2024)
Kristian W Antonsen, Anne G Jensen, Mikkel Carstensen, Lene N Nejsum, Boe Sandahl Sørensen, Anders Etzerodt, Søren Kragh Moestrup, Holger J Møller
Proinflammatory polarization strongly reduces human macrophage in vitro phagocytosis of tumor cells in response to CD47 blockade. European journal of immunology 54 (7) (2024)
Kristian W Antonsen, Anne G Jensen, Mikkel Carstensen, Lene N Nejsum, Boe Sandahl Sørensen, Anders Etzerodt, Søren Kragh Moestrup, Holger J Møller
Proinflammatory polarization strongly reduces human macrophage in vitro phagocytosis of tumor cells in response to CD47 blockade. European journal of immunology 54 (7) (2024)
Christoffer Trier Månsson, Louise Skov Thomsen, Peter Meldgaard, Anders Lade Nielsen, Boe Sandahl Sørensen
Integration of Cell-Free DNA End Motifs and Fragment Lengths Can Identify Active Genes in Liquid Biopsies. International journal of molecular sciences 25 (2) (2024)
Kristian W Antonsen, Anne G Jensen, Mikkel Carstensen, Lene N Nejsum, Boe Sandahl Sørensen, Anders Etzerodt, Søren Kragh Moestrup, Holger J Møller
Proinflammatory polarization strongly reduces human macrophage in vitro phagocytosis of tumor cells in response to CD47 blockade. European journal of immunology 54 (7) (2024)
Kristian W Antonsen, Anne G Jensen, Mikkel Carstensen, Lene N Nejsum, Boe Sandahl Sørensen, Anders Etzerodt, Søren Kragh Moestrup, Holger J Møller
Proinflammatory polarization strongly reduces human macrophage in vitro phagocytosis of tumor cells in response to CD47 blockade. European journal of immunology (2024)
Trine V Larsen, Christoffer Trier Månsson, Tina F Daugaard, Brage Storstein Andresen, Boe Sandahl Sørensen, Anders Lade Nielsen
Trans-Regulation of Alternative PD-L1 mRNA Processing by CDK12 in Non-Small-Cell Lung Cancer Cells. Cells 12 (24) (2023)
Trine V Larsen, Christoffer Trier Månsson, Tina F Daugaard, Brage Storstein Andresen, Boe Sandahl Sørensen, Anders Lade Nielsen
Trans-Regulation of Alternative PD-L1 mRNA Processing by CDK12 in Non-Small-Cell Lung Cancer Cells. Cells 12 (24) (2023)
Simone Stensgaard, Astrid Thomsen, Sofie Helstrup, Peter Meldgaard, Boe Sandahl Sørensen
Plasma Immune Proteins and Circulating Tumor DNA Predict the Clinical Outcome for Non-Small-Cell Lung Cancer Treated with an Immune Checkpoint Inhibitor. Cancers 15 (23) (2023)
Trine V Larsen, Nina Dybdal, Tina F Daugaard, Johanne Lade-Keller, Lin Lin, Boe Sandahl Sørensen, Anders L Nielsen
Examination of the Functional Relationship between PD-L1 DNA Methylation and mRNA Expression in Non-Small-Cell Lung Cancer. Cancers 15 (6) (2023)
Trine V Larsen, Christoffer Trier Månsson, Tina F Daugaard, Brage Storstein Andresen, Boe Sandahl Sørensen, Anders Lade Nielsen
Trans-Regulation of Alternative PD-L1 mRNA Processing by CDK12 in Non-Small-Cell Lung Cancer Cells. Cells 12 (24) (2023)
Signe Neldeborg, Johannes Frasez Soerensen, Charlotte Thornild Møller, Marie Bill, Zongliang Gao, Rasmus O Bak, Kasper Holm, Boe Sandahl Sørensen, Mette Nygaard, Yonglun Luo, Peter Hokland, Magnus Stougaard, Maja Ludvigsen, Christian Kanstrup Holm
Dual intron-targeted CRISPR-Cas9-mediated disruption of the AML RUNX1-RUNX1T1 fusion gene effectively inhibits proliferation and decreases tumor volume in vitro and in vivo. Leukemia (2023)
Trine V Larsen, Christoffer Trier Månsson, Tina F Daugaard, Brage Storstein Andresen, Boe Sandahl Sørensen, Anders Lade Nielsen
Trans-Regulation of Alternative PD-L1 mRNA Processing by CDK12 in Non-Small-Cell Lung Cancer Cells. Cells 12 (24) (2023)
Trine V Larsen, Christoffer Trier Månsson, Tina F Daugaard, Brage Storstein Andresen, Boe Sandahl Sørensen, Anders Lade Nielsen
Trans-Regulation of Alternative PD-L1 mRNA Processing by CDK12 in Non-Small-Cell Lung Cancer Cells. Cells 12 (24) (2023)
Trine V Larsen, Christoffer Trier Månsson, Tina F Daugaard, Brage Storstein Andresen, Boe Sandahl Sørensen, Anders Lade Nielsen
Trans-Regulation of Alternative PD-L1 mRNA Processing by CDK12 in Non-Small-Cell Lung Cancer Cells. Cells 12 (24) (2023)
Trine V Larsen, Nina Dybdal, Tina F Daugaard, Johanne Lade-Keller, Lin Lin, Boe Sandahl Sørensen, Anders L Nielsen
Examination of the Functional Relationship between PD-L1 DNA Methylation and mRNA Expression in Non-Small-Cell Lung Cancer. Cancers 15 (6) (2023)
Rie H Nygaard, Marlene C Nielsen, Kristian W Antonsen, Carsten S Højskov, Boe Sandahl Sørensen, Holger J Møller
Metabolism of 25-Hydroxy-Vitamin D in Human Macrophages Is Highly Dependent on Macrophage Polarization. International journal of molecular sciences 23 (18) (2022)
Sara Bønløkke, Magnus Stougaard, Boe Sandahl Sørensen, Berit Bargum Booth, Estrid V S Høgdall, Gitte-Bettina Nyvang, Jacob Christian Lindegaard, Jan Blaakær, Jesper Bertelsen, Katrine Fuglsang, Mikael Lenz Strube, Suzan Lenz, Torben Steiniche
The Diagnostic Value of Circulating Cell-Free HPV DNA in Plasma from Cervical Cancer Patients. Cells 11 (14) (2022)
Jesper Geert Pedersen, Mateo Sokac, Boe Sandahl Sørensen, Adam Andrzej Luczak, Ninna Aggerholm-Pedersen, Nicolai Juul Birkbak, Trine Heide Øllegaard, Martin Roelsgaard Jakobsen
Increased Soluble PD-1 Predicts Response to Nivolumab plus Ipilimumab in Melanoma. Cancers 14 (14) (2022)
Stine Karlsen Oversoe, Michelle S Clement, Michael H Pedersen, Britta Weber, Niels Kristian Aagaard, Gerda Elisabeth Villadsen, Henning Grønbæk, Stephen Jacques Hamilton-Dutoit, Boe Sandahl Sørensen, Jens Kelsen
TERT promoter mutated circulating tumor DNA as a biomarker for prognosis in hepatocellular carcinoma. Scandinavian journal of gastroenterology 55 (12) (2020)